ASCO Election 2026: Meet the 11 Candidates for Leadership Positions
AbbVie Submits Etentamig BLA to FDA for Relapsed/Refractory Multiple Myeloma
PHERGain Five-Year Results: Chemotherapy-Free HER2-Positive Breast Cancer Treatment Shows Durable Outcomes as ctDNA Refines Risk Assessment
Methotrexate for Osteosarcoma: Uses, Benefits and Side Effects
Marzia Zambon Highlights Europa Donna's Participation at ESMO 2026
What’s New On Radiotherapy of Prostate Cancer in 2026?
Lykke Hinsch Gylvin։ Boehringer Ingelheim and Microsoft Explore AI and Digital Twins to Accelerate Clinical Research
Why Women Still Face Barriers at the Top of Medical Research? - CancerWorld
OncoDaily IO is the dedicated immuno-oncology platform of OncoDaily, focused on the rapidly evolving science and clinical practice of cancer immunotherapy. It covers the full spectrum of immuno-oncology, including immune checkpoint blockade, cellular therapies, therapeutic cancer vaccines, antibody-based strategies, oncolytic viruses, next-generation immunomodulatory approaches, tumor microenvironment, immune biomarkers, neoantigens, treatment response and resistance, and personalized immunotherapy. Through OncoDaily IO, readers can follow the latest clinical trials, pivotal studies, translational research, regulatory decisions, emerging therapies, major congress highlights, and interviews with leading international experts advancing cancer prevention, control, and treatment through immunotherapy.
